Sam works as a Consultant Urological Surgeon at Colchester Hospital University Foundation Trust and is an Honorary Senior Lecturer at the University of London and Anglia Ruskin University. He has an interest in lower urinary tract dysfunction and stone disease. He also has an active role in teaching both undergraduates and post graduates and has a formal qualification in medical education. He has completed a Urology Foundation travelling fellowship in Ahmedabad, India.
He has published 15 peer-reviewed papers, 40 published abstracts, and 5 book chapters. He has also won prizes for his work from the American Urological Association, European Urological Association, International Continence Society and Royal Society of Medicine (x2).
Furthermore, he has been featured in the media talking about urological issues, on topics such as kidney stones.
Sam offers specialist treatment in stones and those with bladder/prostate problems across East Anglia. If you have concerns with an elevated PSA, recurrent infections, blood in the urine or problems with your erections a detailed diagnostic workup and treatment is provided.
He has developed particular expertise in the management of patients with urinary stone disease with minimally invasive surgery and the prevention of stones.
He sees female patients with bladder problems as well as children with paediatric urological conditions requiring both medical and surgical management.
For private prostate treatment in East Anglia, Sam is able to provide you with the attention you need as one of our expert urology surgeons.
Sam Datta trained at the University College London Medical School and graduated with Distinction and the Lord Liston Surgical Prize in 2000. He trained on the Hammersmith Surgical Rotation and subsequently on the Imperial Urology Rotation for higher surgical training. Sam undertook a Royal College of Surgeons research fellowship with Professor Clare Fowler in the Department of Uro-neurology at the Institute of Neurology, Queen Square, London where he completed his masters and doctoral theses.
He is the undergraduate tutor for urology at Colchester Hospital and has a postgraduate certificate in medical education.
- Royal College of Surgeons
- British Association of Urological Surgeons
- European Association of Urologists
- Society of Endourology
He has published widely in the field of urology and his research interests include the effect of drugs on the lower urinary tract and stone disease. His MD thesis at the University of London is on Botox and its effects on the bladder.
Key journal publications include:
Prospective outcomes of 13F ultra-mini percutaneous nephrolithotomy (UMP): a consecutive cohort study.
SN Datta, R Solanki, J Desai
J Urol. 2015 Oct 18. pii: S0022-5347(15)05003-X. doi: 10.1016/j.juro.2015.07.123
Novel anticoagulants and antiplatelet agents; a guide for the urologist
G Ellis, AJ Camm, SN Datta – BJU international, 2015
The acute management of iatrogenic urological injuries; strategies and mind-set for the urologist attending an unfamiliar operating theatre.
Datta S, Wheatstone S, Challacombe B.
BJU Int. 2013 Jul 4. doi: 10.1111/bju.12088 PMID: 23826892
Bacteruria management chapter; Problem based urology
Editiors: Drs. Gontero, Kirby, & Carson
ISBN-13: 978-1447146339
Investigation and treatment of bladder dysfunction in diseases affecting the autonomic nervous system – (Chapter in – Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System – Fourth Edition )
Soumendra N Datta & Clare J Fowler
Edited by Christopher J. Mathias and Roger Bannister
Oxford University Press
Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders and changes with Botulinum neurotoxin administration.
S N Datta, A Roosen, A Pullen, R Popat, T P Rosenbaum, S Elneil, P Dasgupta, C J Fowler, A Apostolidis
J Urology 2010 Dec;184(6):2578-85. Epub 2010 Oct 28
Neurogenic bladder dysfunction: Pharmacological interventional approaches (Chapter in – Pelvic organ dysfunction in neurological disease. Edited by Clare J Fowler, Jailesh Panicker, Anton Emmanuel)
Apostolos Apostolidis, Soumendra Datta, Xavier Game and Shahid Khan
Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment.
Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A.
Eur Urol. 2008 Nov 18. PMID: 19054608
Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin
Type A
Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ
Eur Urol. 2008 2008 Jun;53(6):1245-53
Sacral Neuromodulation and Botulinum Toxin
Soumendra Datta and Sohier Elneil
Chapter in Key Advances in Overactive Bladder
RSM Press
Sacral neuro-modulation for urinary retention: UK Single Centre 10 year experience
SN Datta, C Chaliha, A Singh, G Gonzales, B C Kavia, V Mishra, N Kitchen, C J Fowler and S Elneil
BJU Int. 2008 Jan;101(2):192-6. Epub 2007 Oct 26
A case of scrotal sarcoidosis that mimicked tuberculosis
S N Datta A Freeman C N Amerasinghe T Rosenbaum
Nature Clin Pract Urol. 2007 Apr
Guide to treatment of Painful Bladder Syndrome
S N Datta
Charter Continence Care April 2007
Letter to The treatment of female bladder outlet obstruction
Datta SN and Fowler CJ.
BJU Int. 2007 Jan;99(1):211-2; author reply 212.
Results of Double-Blind Placebo-Controlled Crossover Study of Sildenafil Citrate (Viagra) in Women Suffering from Obstructed Voiding or Retention).
Datta SN, Kavia RB, Gonzales G, Fowler CJ.
Eur Urol. 2007 Feb;51(2):489-97.
Urinary retention in women: its causes and management.
Kavia RB, Datta SN, Dasgupta R, Elneil S, Fowler CJ.
BJU Int. 2006 Feb;97(2):281-7.
A neurological approach to retention and obstructed voiding in women.
Soumendra Datta & Clare Fowler
European Urology Today, Vol 17- No 2; 28-29
[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumour presenting with recurrent Cushing’s syndrome
A Markou, P Manning, B Kaya, S N Datta, J B Bomanji and G S Conway
European Journal of Endocrinology,Vol 152, Issue 4, 521-525
Fowler’s syndrome website – S N Datta, S S J Datta, R Kavia & C J Fowler
http://www.ion.ucl.ac.uk/fowlersyndrome/
Key presentations include:
Randomised controlled trial of UMP versus retrograde intrarenal surgery in the treatment of 10-30mm calculi
Liverpool – Best of BAUS
Assessment of the efficacy of Colchester General Hospital’s Stone Unit Pathway – Challenges in Endourology Paris
Randomised controlled trial of UMP versus retrograde intrarenal surgery in the treatment of 10-30mm calculi
San Diego – American Association of Urology
Randomised controlled trial of UMP versus retrograde intrarenal surgery in the treatment of 10-30mm calculi
Munich – European Association of Urology
Early UK experience of ultra-mini PCNL
World Congress of Endourology 2015 (poster)
Prospective outcomes of ultra-mini percutaneous nephrolithotomy (UMP): a consecutive cohort study.
British Association of Urological Surgeons – Poster presentation
Prospective outcomes of ultra-mini percutaneous nephrolithotomy (UMP): a consecutive cohort study.
EAU Madrid – Poster presentation
Can urology trainees achieve operative target volumes set by the Joint Committee of Surgical Training (JCST)?
BAUS Poster Presentation P35
Urology Trainee operative outcomes
2nd Prize Spring Short Papers- Royal Society of Medicine
Synaptosomal-associated protein 25 (SNAP-25) and Neuropeptide Y in the overactive human bladder and the effect of Botulinum neurotoxin type A (BoNT/A) – BAUS Annual Meeting – Moderated Poster presentation Glasgow
Robotic Partial Nephrectomy compared to Open Partial Nephrectomy in a District General Hospital – Section of BAUS Oncology Meeting
Outcomes of Sacral Neuromodulation in female urinary retention – French Urological Society – Abstract 246
Cholinergic signalling pathways in the superficial layers of the human bladder; comparing health, disease and the effect of Botulinum Toxin Type A. *Prize Winning Presentation* (Best of AUA – Incontinence section)
AUA Meeting – Chicago
Superficial muscarinic receptors (M2 and M3) in patients with detrusor overactivity (DO) and the effect of Botulinum toxin type A (BoNT/A).
BAUS Meeting – Manchester
Suburothelial Myofibroblasts in the Overactive Bladder
Queen Square Symposium – London
Suburothelial muscarinic receptors M1, M2, M3 in patients with detrusor overactivity (DO) and the effect of Botulinum toxin type A (BoNT/A). *Prize winning* European Association of Urology Meeting – Milan
5 year experience with Botulinum toxin A for the treatment of detrusor overactivity. World Congress of Endourology – Cancun
Female Voiding Dysfunction: A Tertiary Centre Experience.
International Continence Society – Rotterdam
M1 muscarinic receptor immunohistochemistry in detrusor overactivity before and after treatment with Botulinum toxin
British Association of Urological Surgeons Meeting – Glasgow – Podium presentation
UK experience of Sacral neuromodulation in urinary retention – 10 year experience
British Association of Urological Surgeons Meeting – Glasgow – Poster presentation
Sacral neuromodulation in urinary retention – 10 year experience
American Urological Association – Poster presentation
Female Voiding Dysfunction 2001-2006 – UK Experience
European Association of Urology – Berlin
10 year experience of Sacral Neuromodulation for Urinary Retention – results from a tertiary UK referral Centre
European Association of Urology – Berlin
Histological changes in the human bladder urothelium and suburothelium following injections of Botulinum neurotoxin type A (BoNT/A) for the treatment of neurogenic versus idiopathic detrusor overactivity (NDO/IDO) *Prize Winning*
International Continence Society – Christchurch
Results of double blind placebo controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation
Society of International Urology – Cape Town
UK experience of 2-stage Sacral Neuromodulation for women with urinary retention
Society of International Urology – Cape Town
Histological Changes in the Superficial Layers Of The Human Bladder Following Injections of Botulinum Neurotoxin Type A (BoNT/A) For The Treatment Of Detrusor Overactivity
World Congress of Endo-urology 2006 Cleveland
Effect of Sildenafil Citrate (Viagra), in women suffering from Obstructive Voiding or Retention associated with the Primary
Disorder of Sphincter Relaxation
BAUS Annual Meeting 2006 – Manchester
The first UK report of minimally invasive staged sacral nerve stimulation implants for urinary retention.
BAUS Annual Meeting 2006 – Manchester
Pitfalls in the new Clinical Trials Application Process
European Society for Study of Interstitial Cystitis
– Annual Meeting – London
Audit of efficacy and safety of Neuromodulation for women with Urinary Retention
National Hospital for Neurology & Neurosurgery
Painful Bladder Syndrome – A Clinical Trial
Royal College of Surgeons Research Fellowship
UK Experience of 2 stage Sacral Neuromodulation for women with Urinary Retention
RSM Geoffrey Chisholm Prize Meeting / BAUS Endourology – Freeman Hospital, Newcastle
Urinary Retention in Women – Fowler Syndrome
Association of Continence Advisors Regional Meeting
“Sildenafil Citrate in Voiding Dysfunction”
Urological Research Society – London
“A Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Sildenafil Citrate (Viagra), in Patients Suffering from Obstructive Voiding or Retention Associated With the Primary Disorder of Sphincter Relaxation” (Abstract 299)
International Continence Society – Poster / Montreal
“Necrotising Scrotal Sarcoidosis – Beware of the Odd Balls” Prize winning podium presentation – Royal Society Medicine
“Tubeless Percutaneous Nephrolithotomy (PCNL) – When not to do it!”
Poster Presentation – BAUS Section of Endo-urology
4th Annual Meeting – Manchester
“Transurethral ethanol ablation of the prostate (TEAP) in high risk patients under local anaesthesia – preliminary results”
Podium Presentation – BAUS Section of Endo-urology
4th Annual Meeting – Manchester
“Imaging with Radio-Labelled Monoclonal Antibody specific to PSMA in staging prostatic carcinoma”
Podium Presentation – American Urological Association 99th Annual Meeting – San Francisco
“incidence & Treatment of Post-operative nausea & Vomiting in a London Teaching”
Current Controversies in Anaesthesia, Dingle, Ireland
“Thymic Carcinoid Tumour presenting with recurrent Cushing’s Syndrome”
Royal Society of Medicine – Endocrinology Section
“Vascular Hyporeactivity in Perniosis and Acrocyanosis”
American Academy of Dermatology – Chicago, USA
“Investigation of Cutaneous Neural and Endothelial
Peptides in Acrocyanosis and Perniosis”
Charite Medical School – Berlin, Germany
